We launched COVID Vaccine Facts, a new website with scientific and evidence-based information related to the COVID-19 vaccine development process. More details below, plus a look at the benefits of biotech crops. (663 words, 3 minutes, 18 seconds)
BIO launched a new website to help patients and their families understand and enroll in clinical trials—we have details. Plus, BIO weighed in on today’s House Agriculture Committee hearing on America’s renewable economy, and we may soon have an…
BIO launched an important new agenda to eliminate racial disparities in the industry and health care delivery. We’ve got the details, in around 670 words, just under 4 minutes.
New research underlines the value of patents for development of COVID-19 vaccines and therapeutics, and the danger of waivers—plus, the bull market on climate solutions. (654 words, 3 minutes, 16 seconds)
A new report lays out the financial and human costs of a planned Mexican ban on biotech corn, and Dr. Michelle's latest podcast investigates how monkeypox can inform pandemic preparation. (753 words, 3 minutes, 45 seconds)
Treating mental illness requires awareness—the impetus for Mental Health Awareness Week—as well as efforts from biotech. In a sign of the times, Shell is reportedly planning to replace an old oil refinery with a biorefinery making SAFs. (664 words, 3 minutes, 19 seconds)
Ending the last week before the October recess with a busy day on Capitol Hill, with Congress passing SBIR/STTR yesterday and the continuing resolution with PDUFA expected to pass today. Also, we recap yesterday's Senate hearing on limiting sensitive foreign investment in research. (757 words, 3 minutes, 47 seconds)For your weekend entertainment, remember to listen to the latest I am BIO podcast, "Data Storage Crisis: DNA to the Rescue," on Apple, Google, or Spotify.
Today, we have good news from Oregon on Accelerated Approval, and what USDA’s doing to advance ag biotech in response to climate change. Meanwhile, we’re awaiting news from Capitol Hill regarding the reauthorization of SBIR/STTIR and PDUFA any moment now, with passage of both expected before the Sept. 30 deadline. (764 words, 3 minutes, 49 seconds)
The Biden administration released a food strategy ahead of today’s White House food security conference—we have details and how biotech can help. Plus, how governments are tackling non-communicable diseases and promising news from an Eisai and Biogen Alzheimer’s trial. (635 words, 3 minutes, 10 seconds)
We have more on the problems with the 340B program and the growing calls for the U.S. to take action on Mexico's GM corn ban. Plus, work continues on the Continuing Resolution before government funding expires on Friday evening. (671 words, 3 minutes, 21 seconds)And don't forget to listen to the latest I am BIO podcast exploring society's impending data storage problem and how DNA is being used to fix it. Listen now on Apple, Google, and Spotify.
BIO’s calling out the inconsistency between Biden’s new biotech EO and U.S. support for an expanded COVID IP waiver—plus, the Dept. of Energy released a roadmap to achieve major SAF and emissions goals. (672 words, 3 minutes, 21 seconds)
Ending the week with USDA nominee Alexis Taylor’s hearing at the Senate Ag Committee, BIO’s webinar on the impacts of the new drug price controls—and a deal on prescription drug user fees. Enjoy the weekend. (883 words, 4 minutes, 24 seconds)
Today we look at the investment landscape for sickle cell disease and an alarming new climate report that shows the need for biotech solutions, plus two brand-new reports showing both progress and setbacks in fighting cancer and other non-communicable diseases. (685 words, 3 minutes, 25 seconds)
